United Therapeutics | UTHR - Beneficio Bruto En Ventas

Precio De Mercado
571.73
Cambio Diario
-3.04 -0.53%
Mensual
4.96%
Anual
103.35%
Q2 Expectativa
556.12




Beneficio Bruto En Ventas Cambio Fecha
Amarin USD 23.17M 961K 2025-12
Ardelyx USD 114.37M 8.02M 2025-12
Baxter International USD 577M 373M 2025-12
Bayer EUR 5.35B 1.02B 2025-09
BioCryst Pharmaceuticals USD 153.05M 4.16M 2025-12
Biogen USD 1.65B 34.6M 2025-12
BioMarin Pharmaceutical USD 713.01M 81.81M 2025-12
Esperion Therapeutics USD 140.59M 94.57M 2025-12
Gilead Sciences USD 6.31B 106M 2025-12
GlaxoSmithKline GBP 6.18B 106M 2025-12
Halozyme Therapeutics USD 281.77M 2.41M 2025-09
Insmed USD 217.69M 106.25M 2025-12
Ionis Pharmaceuticals USD 195M 40M 2025-12
J&J USD 16.6B 118M 2025-12
Lexicon Pharmaceuticals USD 5.29M 8.88M 2025-12
Moderna USD 226M 583M 2025-12
Omeros USD -33.16M 18.52M 2024-06
Pfizer USD 3.54B 7.61B 2025-09
PTC Therapeutics USD 148.38M 39.31M 2025-12
Regeneron Pharmaceuticals USD 3.3B 67M 2025-12
Sangamo BioSciences -2.39M 1.09M 2024-06
Sarepta Therapeutics USD 43.55M 204.36M 2025-12
Teva Pharmaceutical Industries USD 2.66B 351M 2025-12
United Therapeutics USD 315.5M 286.6M 2025-12
Vertex Pharmaceuticals USD 2.72B 62.4M 2025-12